Clinical Evidence: GLP-1s and Sperm Health Recent research from the AUA 2025 study 3 provides compelling evidence that GLP-1 receptor agonists (GLP-1 RAs), like semaglutide, have a significant connection in improving sperm count in overweight and obese men
To identify a putative mechanism by which GLP-1(2836) stimulates ATP production, we conducted an affinity pull-down experiment with our functional biotinylated GLP-1(2836) followed by unbiased mass spectroscopy to identify potential binding partners for GLP-1(2836) in the mouse heart (Supplemental Figures 911)
Finally, we show with pharmacological inhibitors (KH7) and gene silencing (siRNA) that sAC-mediated actions of GLP-1(2836) were conserved in human caSMCs
Novel inhibitors targeting insulin-related signal pathways, including ONC201 (AKT inhibitor), LY294002 (PI3K inhibitor), received satisfying results in preclinical studies (Fujiwara et al., 2008
User agrees and understands that the use of the Website is for individuals only and is prohibited from use by non-individuals or their agents, attorneys, or attorney representatives
Insulin sensitizers improve the GLP-1 secretion and the amount of intestinal L cells on high-fat-diet-induced catch-up growth
